Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blessy George

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The American Journal of Emergency Medicine|February 26, 2017
Remote management of low to intermediate risk chest pain: A case seriesAlexander Chiu, Kathleen Shumaker, Christopher Del Corral, et al.
Toxicology Reports|May 9, 2020
Time-dependent changes in kidney injury biomarkers in patients receiving multiple cycles of cisplatin chemotherapyBlessy George, Xia Wen, Nickie Mercke, et al.
Clinical Pharmacology and Therapeutics|December 22, 2016
Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time-dependent Changes in the Absence of Clinical NephrotoxicityBlessy George, Xia Wen, Nickie Mercke, et al.
International Journal of Molecular Sciences|June 23, 2017
Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving CisplatinCara Chang, Yichun Hu, Susan L Hogan, et al.
The American Journal of Emergency Medicine|November 8, 2017
Corrigendum to "Remote management of low- to intermediate-risk chest pain: a case series" (Am J Emerg Med [2017])Alexander Chiu, Kathleen Shumaker, Christopher Del Corral, et al.
European Journal of Clinical Pharmacology|September 17, 2018
Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patientsMustafa E Ibrahim, Cara Chang, Yichun Hu, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The American Journal of Emergency Medicine|February 26, 2017
Remote management of low to intermediate risk chest pain: A case seriesAlexander Chiu, Kathleen Shumaker, Christopher Del Corral, et al.
Toxicology Reports|May 9, 2020
Time-dependent changes in kidney injury biomarkers in patients receiving multiple cycles of cisplatin chemotherapyBlessy George, Xia Wen, Nickie Mercke, et al.
Clinical Pharmacology and Therapeutics|December 22, 2016
Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time-dependent Changes in the Absence of Clinical NephrotoxicityBlessy George, Xia Wen, Nickie Mercke, et al.
International Journal of Molecular Sciences|June 23, 2017
Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving CisplatinCara Chang, Yichun Hu, Susan L Hogan, et al.
The American Journal of Emergency Medicine|November 8, 2017
Corrigendum to "Remote management of low- to intermediate-risk chest pain: a case series" (Am J Emerg Med [2017])Alexander Chiu, Kathleen Shumaker, Christopher Del Corral, et al.
European Journal of Clinical Pharmacology|September 17, 2018
Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patientsMustafa E Ibrahim, Cara Chang, Yichun Hu, et al.
Pageof 2